About BioActives:
BioActives produces value-added highly water-soluble and highly bioavailable lipophilic active ingredients using its patented processes. The company’s line of MicroActive^® ingredients demonstrate superior bioavailability in uptake amount and consistency thereby reducing inter-subject variance. MicroActive^® ingredients assure consumers maximum efficacy regardless of diet, health condition or risk factors – they are cost-effective and easily formulated.

Bioavailability is a key and sometimes overlooked factor in producing cost/effective nutraceuticals says Dr. Kagan a partner at BioActives. Cyclodextrins have been shown in both the food and pharmaceutical industries to improve dispensability and uptake.

“We are doubly pleased with this patent issuance because it not only adds to our MicroActive^® line of more bioavailable products, including Lutein, but also further validates our NanoNutrient^® Technology for improving the uptake of lipophilic compounds,” says Dr. Kagan.

The MicroActive^® product line increases the uptake and consistency of absorption for lipophilic compounds by using active carriers such as cyclodextrins and reducing particle size through a proprietary process. Lipophilic compounds require other lipid-based compounds for absorption in the intestine and have been shown to have highly variable uptake. MicroActive™ ingredients are water dispersible and do not require fats for absorption. Additionally, BioActives technology enhances cell transport another factor improving bioavailability. The Company is developing additional compounds focused on the food and sports nutrition industries.